Clinical Trial Update: Erlotinib Pharmacokinetics During Doxycycline Treatment for Erlotinib-induced Rash [NA]

View source ↗

Summary

A clinical trial assessing Erlotinib pharmacokinetics during doxycycline treatment for Erlotinib-induced rash has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Doxycycline (Doxycycline)
• ERLOTINIB (Erlotinib)

Snippet

Sponsor: Northwestern University | Conditions: Non Small Cell Lung Cancer | NA | Status: WITHDRAWN